Brown Capital Management Has Raised By $463,452 Its Gw Pharmaceuticals Plc (GWPH) Position; TECHNICOLOR ORDINARY SHARES PROV DE REGR (THNRF) Sellers Increased By 8.96% Their Shorts

April 22, 2018 - By Kurt Siggers

Technicolor SA (OTCMKTS:THNRF) Logo

TECHNICOLOR ORDINARY SHARES PROV DE REGR (OTCMKTS:THNRF) had an increase of 8.96% in short interest. THNRF’s SI was 1.14 million shares in April as released by FINRA. Its up 8.96% from 1.05M shares previously. The SI to TECHNICOLOR ORDINARY SHARES PROV DE REGR’s float is 0.31%. It closed at $1.68 lastly. It is down 0.00% since April 22, 2017 and is . It has underperformed by 11.55% the S&P500.

Brown Capital Management Llc increased Gw Pharmaceuticals Plc (GWPH) stake by 10.4% reported in 2017Q4 SEC filing. Brown Capital Management Llc acquired 3,511 shares as Gw Pharmaceuticals Plc (GWPH)’s stock declined 18.69%. The Brown Capital Management Llc holds 37,280 shares with $4.92 million value, up from 33,769 last quarter. Gw Pharmaceuticals Plc now has $3.74 billion valuation. The stock decreased 1.24% or $1.66 during the last trading session, reaching $132.43. About 674,521 shares traded or 66.19% up from the average. GW Pharmaceuticals plc (NASDAQ:GWPH) has declined 9.18% since April 22, 2017 and is downtrending. It has underperformed by 20.73% the S&P500.

Brown Capital Management Llc decreased Veeva Sys Inc (NYSE:VEEV) stake by 191,104 shares to 5.80M valued at $320.89 million in 2017Q4. It also reduced Guidewire Software Inc (NYSE:GWRE) stake by 405,094 shares and now owns 3.46M shares. Paycom Software Inc (NYSE:PAYC) was reduced too.

Among 13 analysts covering GW Pharmaceuticals (NASDAQ:GWPH), 11 have Buy rating, 1 Sell and 1 Hold. Therefore 85% are positive. GW Pharmaceuticals had 30 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Maxim Group on Monday, August 7. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) has “Buy” rating given on Tuesday, August 8 by Cantor Fitzgerald. The rating was maintained by Leerink Swann on Thursday, December 28 with “Buy”. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Goldman Sachs on Thursday, December 14. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Bank of America on Tuesday, February 6. As per Monday, March 14, the company rating was maintained by Roth Capital. As per Thursday, August 3, the company rating was maintained by Piper Jaffray. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Cantor Fitzgerald on Monday, September 26. The company was maintained on Tuesday, April 17 by Cantor Fitzgerald. The firm earned “Buy” rating on Wednesday, April 18 by Cowen & Co.

Technicolor SA provides various communication and video technologies, finished products, systems, equipment, and services for businesses and professionals in the entertainment and media industries worldwide. The company has market cap of $633.50 million. It operates through three divisions: Connected Home, Entertainment Services, and Technology. It currently has negative earnings. The Connected Home segment creates and supplies set-top boxes, broadband modems and gateways, managed wireless tablets, and other connected devices, as well as multi-device communication software, smart home applications, and related professional services.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>